You have no items in your shopping cart.
Human FGF-18 [orb3002529]SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE. (QC verified)
Predicted: 21.9kDa. Observed: 25-37kDa, reducing conditions
1 mg, 500 μg, 50 μg, 10 μg- Mouse FGF-10 [orb3002530]
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 17.1KDa. Observed: 17 KDa, reducing conditions
1 mg, 500 μg, 50 μg, 10 μg - Human FGFb [orb3002475]
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.. SEC-HPLC: Greater than 95% as determined by SEC-HPLC. (QC verified)
Predicted: 16.3 KDa. Observed: 17 KDa, reducing conditions
10 μg, 50 μg, 500 μg, 1 mg - Human FGF-10 [orb3002478]
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 19.5 KDa. Observed: 19-22 KDa, reducing conditions
10 μg, 50 μg, 500 μg, 1 mg - Human KGF [orb3002467]
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 18.9 KDa. Observed: 17 KDa, reducing conditions
10 μg, 50 μg, 500 μg, 1 mg - Human FGFa [orb3002211]
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 17.3 KDa. Observed: 17 KDa, reducing conditions
10 μg, 50 μg, 500 μg, 1 mg - Human FGF-4 [orb3002220]
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 15.1 KDa. Observed: 14 KDa, reducing conditions
10 μg, 50 μg, 1 mg, 500 μg - Human FGF-17 [orb3002224]
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 22.6 KDa. Observed: 22 KDa, reducing conditions
10 μg, 50 μg, 500 μg, 1 mg - Mouse FGF-4 [orb3002280]
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 15.2 KDa. Observed: 15 KDa, reducing conditions
10 μg, 50 μg, 500 μg, 1 mg - Cynomolgus FGF-21 [orb3002238]
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 20.2 KDa. Observed: 19-24 KDa, reducing conditions
10 μg, 50 μg, 500 μg, 1 mg